To test whether POSTN or MDK could directly affect the responsiveness of melanoma cells to MAPK inhibitors, we first identified primary melanoma cell lines displaying either high or low endogenous POSTN and MDK expression (M150325, M131205 and M150543, M161201, respectively; Figures S3A and S3B). Here, POSTN is linked to melanoma.